Top HHS Drug-Pricing Official Leaves, Replaced By Medicare Deputy

By Rachel Cohrs
August 12, 2019 at 4:37 PM
John O’Brien, HHS’ top drug-pricing official, is stepping down after nine months and will be replaced by John Brooks, the principal deputy director of the Center for Medicare and formerly a White House Domestic Policy Council official, HHS announced Monday (Aug. 12). The departure comes after several of President Donald Trump’s marquee drug-pricing policies were blocked or pulled in recent months. HHS Secretary Alex Azar highlighted O’Brien’s role in creating the administration’s drug-pricing blueprint in a statement on O’Brien’s departure...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.